Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anterix Inc. Director's Dealing 2021

Feb 4, 2021

33018_dirs_2021-02-03_894181ba-6095-4a39-a218-621db058d5be.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Anterix Inc. (ATEX)
CIK: 0001304492
Period of Report: 2021-02-01

Reporting Person: Schwartz Robert Harris (President and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-02-01 Common Stock A 45000 $0.00 Acquired 85850 Direct

Footnotes

F1: The performance-based restricted stock units (the "Units") vest upon the Reporting Person's continued service and achievement of certain stock price levels calculated utilizing a four-year compound annual growth rate and based on the average closing bid price per share of the Issuer's common stock measured over a sixty (60) trading-day period. The Reporting Person may vest in a minimum of 25% of the target reported Units and up to a maximum of 350% of the target reported Units based on specified stock price levels. The vesting end measurement date is February 1, 2025, with earlier vesting determination dates upon a change in control of Issuer, the involuntary termination of the Reporting Person or twelve (12) months following the achievement of the maximum stock price level. If after February 1, 2023, the Reporting Person achieves a stock price level, there will be a vesting determination date the earlier of 12 months thereafter or February 1, 2025.